ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants

April 12, 1974

No Benefit To Shark Cartilage As Treatment, Large Trial Finds

July 27, 2007

NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period

October 18, 1985

Cervarix Vaccine Approved To Prevent Cervical Cancer

October 30, 2009

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010

NCI Awards $10 Million To States for Cervix Screening

September 27, 1974